Chris leads our private equity consulting practice, IGNITE Health Advisors.

Chris is an executive with repetitive successes in delivering double-digit profitable organic growth; supporting companies as they transform and scale from lower to upper middle market. Chris has over 20 years’ experience as a executive holding senior commercial and general management roles (CEO, CCO, VP S&M) within clinical and diagnostic services, invitro device distribution, molecular tools and nutraceuticals. He has a track-record of exceptional share-holder value creation, with a career reputation for working positively alongside colleagues and financial partners.